Method validation for each species [Bioanalytics]

posted by janmacek – Czech Republic, 2016-05-11 15:09 (2904 d 13:42 ago) – Posting: # 16293
Views: 2,147

Dear all,

we are planning validation of a bioanalytical method for the determination of a drug candidate in plasma. This method should be used for the analysis of samples from various species (rat, mouse, dog, etc.). The European Guideline states that full validation should be performed for each species and matrix concerned, while the FDA guideline states that partial validation is required for the change of species within matrix.

What is your experience with this topic? Is the approach really different in Europe and US?

With best regards,

Jan

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
56 visitors (0 registered, 56 guests [including 9 identified bots]).
Forum time: 04:51 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5